He graduated medical school at the University of London in 1967 and worked for several years in medicine and then in medical oncology. He realized that medical oncology was confusing and mainly witchcraft and decided to learn how to do research and was apprenticed at the Imperial Cancer Research Labs, London with Renato Dulbecco. After his molecular biology PhD (5â€²-mRNA capped ends) he moved after his advisorâ€™s Nobel Prize with him to the USA.
Brian I. Carr (Research Area)
His clinical interests have been for a long time in developing new HCC therapies, focussing initially on hepatic chemoembolization and subsequently on Yttrium-90 bead hepatic internal radioembolization and more recently on vitamin K as HCC therapy. Currently, he is analyzing HCC databases involving several thousand patients, to identify HCC phenotypes with differing clinical parameter patterns and prognoses. The main findings are that context is key, and that any given parameter (such as serum bilirubin or tumor mass) can only be understood in its total clinical context.
Dr. Carmelo Cuffari is a pediatric gastroenterologist in Baltimore, Maryland and is affiliated with multiple hospitals in the area, including Greater Baltimore Medical Center and Howard County General Hospital. He received his medical degree from University of Ottawa Faculty of Medicine and has been in practice for more than 20 years.
Carmen Cuffari(Research Area)
Immunomodulatory mechanism of action of anti-metabolite drugs in patients with inflammatory bowel disease; Pharmacogenomics of immunosuppressant drugs in patients with inflammatory bowel disease and in children post-liver transplantation
Prof. Dr. Alireza Heidari, Ph.D., D.Sc. is a Full Professor and Academic Tenure of Chemistry at California South University (CSU), Irvine, California, USA. He has got his Ph.D. and D.Sc. degrees from California South University (CSU), Irvine, California, USA. Furthermore, he has double postdocs in Project Management, Oncology, Human Cancer Tissues and Synchrotron Radiation from Monash University, Melbourne, Victoria, Australia and also in Nanochemistry and Modern Molecular Electronicâ€“Structure Computations Theory from California South University (CSU), Irvine, California, USA.
Alireza Heidari(Research Area)
Biophysical Chemistry, Biomolecular Spectroscopy, Quantum Chemistry, Nanochemistry, Modern Electronic Structure Computations, Theoretical Chemistry, Mathematical Chemistry, Computational Chemistry, Vibrational Spectroscopy, Molecular Modelling, Ab initio & Density Functional Methods, Molecular Structure, Biochemistry, Molecular Simulation, Pharmaceutical Chemistry, Medicinal Chemistry, Oncology
Dr.Abdelrahman Nimeri is head of the Division of General, Thoracic, & Vascular Surgery.He is the Director of Bariatric & Metabolic Institute (BMI) Abu Dhabi and Quality Review Officer of the department of Surgery Institute of Surgery
Dr. Chau-Ting Yeh obtained his MD in National Taiwan University and PhD in Department of molecular microbiology and immunology, University of Southern California. He is the director of Liver Research Center, Chang Gung Memorial Hospital, Taiwan, since 2007. His research interests have focused on (i) HBV antiviral drug-related mutants and their oncogenic potential, and (ii) New strategies to apply genomic markers for precision medicine to treat hepatocellular carcinoma. He has published more than 200 papers in SCI indexed journals.
Chau-Ting Yeh(Research Area)
Medical Technology, and Clinical Pathology
He received his medical degree from the University of Belgrade, Belgrade, Serbia (1977) and became Specialist of Internal Medicine (1983) and Gastroenterology (1988). He received his Master of Science degree (1992) and his PhD degree (1994) in gastroenterology from the University of Tuzla, Tuzla, Bosnia and Herzegovina. Dr Zerem is currently professor of Internal Medicine and coordinator of doctoral study at the University of Tuzla School of Medicine and director for research and education at the University Clinical Center Tuzla.
Enver Zerem(Research Area)
Diagnosis and treatment of acute pancreatitis, the application of interventional ultrasound in gastroenterology and hepatology, acid-related disorders, viral hepatitis and research education and academic training of gastroenterologists and ultrasonographists
Aliaksey Piatkevich was born 05 September, 1973.
He graduated from Polotsk medical college in 1991 and Vitebsk Medical University in 1997 and then worked as an endoscopist in Polotsk cancer center. He has been the chief of the department of endoscopy in the Republican clinical medical center of the presidential administration since 2010. Scientific interest is Colorectal Screening.
Since 2000 research associate of the professional association for health service and welfare (BGW), since 2010 professor at the University Medical Center Hamburg Eppendorf (UKE). Focus: Work-related prevention and rehabilitation research. Specialist in occupational medicine, an epidemiologist
Dr. Antoni worked in Thrombosis Research Center, Temple University Medical School, Philadelphia, USA, having faculty position, investigated a role of plasma and intestinal tissue kallikrein â€“ kinin system in experimental IBD, in collaboration with Prof. Dr RB Sartor, NC, and Chapel Hill, US. Currently working as Professor, Silesian Medical University doing research, medical practice, and teaching students. He has supervised two large research projects founded by Polish Ministry of Sciences related to pathogenesis and treatment of human IBD.He also continued IBD coagulation study to evaluate link of coagulation-inflammation in joints and gut diseases, and anti - platelets agents (Clopidogrel) interactions with proton pump inhibitors. My recent projects were also related to the tissue kallikrein â€“ kinin system, and kinin receptors in colorectal polyps, and colorectal cancer as well as a significance of angiogenesis related to kinins and grow factors in ulcerative colitis.
Antoni Stadnicki(Research Area)
Inflammatory bowel disease (IBD) and other inflammatory disorders, especially a role inflammatory mediators including kallikrein â€“ kinin system and coagulation system and related immunological disorders in pathogenesis, complication and treatment of experimental and human IBD, and other chronic diseases.
Abdolrahman Shams Nateri Completed his doctrate degree on the genetic engineering of Picornavirus, human Parechovirus 1,at the Essex Univ. later on in the year 2001, he joined as a member of Cancer Research UK (CR-UK) London Research Institute (previously known as ICRF), where he carried out his fundamental basic-research into the links between transcription, MAPKs signaling & diseases, including the cellular/molecular biology of cancer and also rewarded with publications with top journals.In 2007, he joined as a faculty of the UoN, where he intially started as a lecturer, and was promoted as an Associate Professor,his endless passion in cancer-biology and excellent achievements boasted publications in Nature, Science, etc and more recently J Exp Med & Stem Cells.
Abdolrahman Shams Nateri(Research Area)
Gastrointestinal (GI) disorders (both neoplastic & non-neoplastic),Cancer Genetics, Transgenic Murine Technology, Stem Cells, Reprogramming of Cancer Cells and Links between Signalling, Transcription and Diseases,cellular basis of IES cell self-renewal, the interaction of stem cells with their specialized microenvironment (stem cell niche) and the relationship between stem cells and tumorigenesis.
Prof Annette Byrne is Associate Professor (Physiology) and Head of the RCSI Laboratory for Tumour Biology and Molecular Imaging (LTBMI) at the Royal College of Surgeons in Ireland.
Annette Byrne (Research Area)
The RCSI LTBMI led by Prof Byrne works primarily on brain and colorectal malignancies with an overarching goal to improve patient outcomes. The Group is concerned with the pre-clinical and clinical development of novel targeted anti-cancer therapeutics and biomarkers with a particular interest in applying a systems based multi-modality molecular imaging approach towards elucidation of drug mechanism of action in vivo.
Particular interest in surgical diseases of the gastrointestinal tract (eg Stomachus, gut, bile, liver, pancreas, spleen etc) and mainly in surgical oncology.
Complete development of methods of laparoscopic surgery and use of Robotic Surgery in accordance with international specifications and according to modern data.